Improving hepatocellular carcinoma surveillance in the United Kingdom: challenges and solutions
-
Published:2024-08
Issue:
Volume:43
Page:100963
-
ISSN:2666-7762
-
Container-title:The Lancet Regional Health - Europe
-
language:en
-
Short-container-title:The Lancet Regional Health - Europe
Author:
Qurashi MariaORCID,
Sharma Rohini
Reference32 articles.
1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019
2. Electronic address, e.e.e. and L. European Association for the Study of the, EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018
3. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study;Arnold;Lancet Oncol,2019
4. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases;Marrero;Hepatology,2018
5. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma;Singal;J Natl Compr Canc Netw,2013